Cargando…

Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials

Axial spondyloarthritis (Ax SpA) refers to chronic inflammatory rheumatic diseases that mainly affect the axial skeleton, leading to erosions and new bone formation in the sacroiliac joints and/or the spine. Ax SpA includes the radiographic form of the disease, ie, ankylosing spondylitis (AS), and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toussirot, Eric, Vauchy, Charline, Binda, Delphine, Michel, Fabrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936813/ https://www.ncbi.nlm.nih.gov/pubmed/27445459 http://dx.doi.org/10.2147/DDDT.S107587

Ejemplares similares

Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials [Corrigendum]
Publicado: (2017)

An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritis
por: Paccou, Julien, et al.
Publicado: (2016)

The Nonradiographic Axial Spondyloarthritis, the Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis: The Tangled Skein of Rheumatology
por: Malaviya, Anand N., et al.
Publicado: (2017)

Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance
por: Ghosh, Nilasha, et al.
Publicado: (2017)

Antiphospholipid Syndrome Associated with Nonradiographic Axial Spondyloarthritis
por: De Carvalho, Jozélio Freire, et al.
Publicado: (2021)

A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis
por: Sieper, J., et al.
Publicado: (2015)

Cortical bone loss is an early feature of nonradiographic axial spondyloarthritis
por: Neumann, Anna, et al.
Publicado: (2018)

Differentiating nonradiographic axial spondyloarthritis from its mimics: a narrative review
por: Mease, Philip, et al.
Publicado: (2022)

Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease: A narrative review
por: Magrey, Marina, et al.
Publicado: (2022)

Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort
por: Hebeisen, Monika, et al.
Publicado: (2020)

Predictive Factors of Clinical Response of Infliximab Therapy in Active Nonradiographic Axial Spondyloarthritis Patients
por: Lin, Zhiming, et al.
Publicado: (2015)

The Effect of Etanercept in Nonradiographic Axial Spondyloarthritis by Stratified C‐Reactive Protein Levels
por: Tam, Hoi Ki Joshua, et al.
Publicado: (2021)

Characterization of Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis in the US‐Based Corrona Registry
por: Mease, Philip J., et al.
Publicado: (2018)

Discriminating Value of Calprotectin in Disease Activity and Progression of Nonradiographic Axial Spondyloarthritis and Ankylosing Spondylitis
por: Huang, Jinxian, et al.
Publicado: (2017)

A Fifty‐Two–Week, Randomized, Placebo‐Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis
por: Deodhar, Atul, et al.
Publicado: (2019)

Is Treatment in Patients With Suspected Nonradiographic Axial Spondyloarthritis Effective? Six‐Month Results of a Placebo‐Controlled Trial
por: Rusman, Tamara, et al.
Publicado: (2021)

Efficacy and safety of golimumab in patients with non-radiographic axial spondyloarthritis: a withdrawal and retreatment study (GO-BACK)
por: Weinstein, Cindy L J, et al.
Publicado: (2023)

Predictors of Assessment of Spondyloarthritis International Society (ASAS) Health Index in Axial Spondyloarthritis and Comparison of ASAS Health Index between Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Data from the Catholic Axial Spondyloarthritis COhort (CASCO)
por: Min, Hong Ki, et al.
Publicado: (2019)

Hearing loss can also be seen in patients with nonradiographic axial spondyloarthropathies as well as radiographic axial spondyloarthropathies
por: Çağlar Yağcı, Hanife, et al.
Publicado: (2023)

The Risk of Cardiovascular Diseases in Axial Spondyloarthritis. Current Insights
por: Toussirot, Eric
Publicado: (2021)

Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52‐Week, Randomized, Controlled Trial
por: Walsh, Jessica A., et al.
Publicado: (2022)

The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current Insights
por: Toussirot, Eric
Publicado: (2022)

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis
por: Hebeisen, Monika, et al.
Publicado: (2019)

Spinal Inflammation in the Absence of Sacroiliac Joint Inflammation on Magnetic Resonance Imaging in Patients With Active Nonradiographic Axial Spondyloarthritis
por: van der Heijde, Désirée, et al.
Publicado: (2014)

Validation of assessment methods for the apparent diffusion coefficient in a clinical trial of axial spondyloarthritis patients treated with golimumab
por: Møller, Jakob M., et al.
Publicado: (2020)

Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort
por: Neuenschwander, Regula, et al.
Publicado: (2020)

Could Sodium Chloride be an Environmental Trigger for Immune-Mediated Diseases? An Overview of the Experimental and Clinical Evidence
por: Toussirot, Eric, et al.
Publicado: (2018)

Mini-Review: The Administration of Apoptotic Cells for Treating Rheumatoid Arthritis: Current Knowledge and Clinical Perspectives
por: Toussirot, Eric, et al.
Publicado: (2021)

The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study
por: Burgos-Varga, Ruben, et al.
Publicado: (2016)

Editorial: Radiographic progression in axial spondyloarthritis
por: Pimentel-Santos, F. M., et al.
Publicado: (2023)

Erratum to: The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study
por: Burgos-Vargas, Ruben, et al.
Publicado: (2016)

Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic axial spondyloarthritis and ankylosing spondylitis
por: Osterhaus, Jane T, et al.
Publicado: (2014)

Active Inflammatory and Chronic Structural Damages of Sacroiliac Joint in Patients With Radiographic Axial Spondyloarthritis and Non-Radiographic Axial Spondyloarthritis
por: Tu, Liudan, et al.
Publicado: (2021)

Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial
por: van der Heijde, Désirée, et al.
Publicado: (2018)

The role of ixekizumab in non-radiographic axial spondyloarthritis
por: San Koo, Bon, et al.
Publicado: (2021)

Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA study
por: Kishimoto, Mitsumasa, et al.
Publicado: (2021)

Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement
por: Toussirot, Éric, et al.
Publicado: (2013)

Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo‐Controlled Phase III Study
por: Deodhar, Atul, et al.
Publicado: (2020)

Pearls and Pitfalls in Diagnosing Non-Radiographic Axial Spondyloarthritis
por: Tsiami, Styliani, et al.
Publicado: (2022)

Is radiographic progression in radiographic axial spondyloarthritis related to matrix metalloproteinase degradation of extracellular matrix?
por: Siebuhr, Anne Sofie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lueevbg7sf3bm4e4d2lbo2me65